The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies with specific traits. Another notable valuation metric for FI is its P/B ratio of 2.96. The P/B ratio pits a stock's market value against its book value, which is defined as total assets minus total liabilities. For comparison, EFX has a P/B of 6.47 ...

The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on July 17. On the other hand, if they miss, the stock may move lower. This credit reporting company is expected to post quarterly earnings of $1.72 per share in its upcoming report, which represents a year-over-year change of +0.6%. Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggreg ...

i E 1 Tom Werner Earnings History Introduction Equifax (NYSE: EF'X) is about to report Q2 earnings on the 17th of July, so I wanted to see what analysts are expecting and give some comments on the company's outlook and what I would like to see in these numbers. According to my updated valuation, the company is still too expensive for me to start a position, and may be for a while, as market participants keep the company on the more expensive side due to momentum, optimism of the future, or a variety of othe ...

By automating and improving access to data that is often hard to verify, Talent Report High School provides instant access to available high school diploma data. It can streamline the verification process for employers by using a single, centralized data source to enable them to hire applicants faster and to provide a unified ordering experience. ABOUT EQUIFAX INC. New Talent Report™ Solution Helps Speed Up High School Diploma Verification for Employers and Screeners Talent Report High School is powered by ...

TORONTO, June 18, 2024 (GLOBE NEWSWIRE) -- According to the latest data from Equifax® Canada's Market Pulse Q1 2024 Business Credit Trends Report, new installment loan originations surged by 74 per cent year-over-year in the second half of 2023. Businesses that raced to meet the Canada Emergency Business Account (CEBA) forgiveness deadline of January 18th, 2024 could potentially be driving this higher-thanseasonal demand. Industrial trades (credit accounts between businesses and suppliers) have seen a signi ...

Equifax® Canada's Market Pulse Q1 2024 Business Credit Trends "While it may feel like CEBA is moving into the rear-view mirror, it's truly a matter of businesses turning to new installment loans to secure their financial stability," said Jeff Brown, Head of Commercial Solutions for Equifax Canada. "Many businesses were focused on the forgiveness deadline and paying back debt to take advantage of this timeline. The increased reliance on these loans has also contributed to a notable rise in delinquencies, par ...

Core Insights - Consumer debt in Canada reached $2.46 trillion at the end of Q1 2024, a 3.5% increase from the previous year, indicating rising financial strain among consumers [2] - Mortgage delinquency rates are climbing in high-priced housing markets like Ontario and British Columbia, with severe delinquency in Ontario exceeding $1 billion for the first time, double the pre-pandemic level [5][6] - The housing market in Alberta showed resilience with a 10.6% increase in new mortgage originations compared to Q1 2023, attributed to high interprovincial migration [4] Consumer Behavior - Consumers are adapting their credit decisions due to financial stress, with many extending mortgage lengths to reduce payments despite longer loan commitments [3] - There has been a nearly 19% increase in the number of credit score checks by consumers compared to the same period last year, indicating a shift towards more proactive financial management [3] - Lender switching has become more common, with 25.8% of consumers choosing different providers in late 2023, up from 21.7% in 2022 [16] Delinquency Trends - Over 1.26 million consumers missed at least one payment in Q1 2024, marking a 12.2% increase from Q1 2023, with Ontario, British Columbia, and Quebec experiencing above-average jumps in missed payments [11] - Delinquency rates for credit cards and other non-mortgage debts are rising, with credit card full-payment rates dropping from 65.6% in 2023 to 64.5% in Q1 2024 [7] - The average loan value for new mortgages reached $321.7K, a 3.1% increase year-over-year, despite a decrease in new mortgage originations [9] Regional Analysis - Ontario's average debt in Q1 2024 was $21,869, with a 2.51% year-over-year increase and a delinquency rate of 1.40%, reflecting a 28.18% rise from the previous year [14] - Alberta's average debt was $24,157, showing a slight decrease of 0.69% year-over-year, with a delinquency rate of 1.70% [14] - Major cities like Toronto and Vancouver have seen delinquency rates rise above pre-pandemic levels, with Toronto's mortgage delinquencies increasing from 0.09% to 0.14% since Q1 2020 [10]

Core Insights - Consumer debt in Canada reached $2.46 trillion at the end of Q1 2024, a 3.5% increase from the previous year [2] - Mortgage delinquency rates are rising, particularly in Ontario and British Columbia, with Ontario's severe delinquency balance exceeding $1 billion for the first time [7][10] - Financial stress is evident as consumers adapt their credit decisions, with a notable increase in lender switching and credit score checks [3][6] Consumer Debt Trends - Total consumer debt rose to $2.46 trillion, marking a 3.5% year-over-year increase [2] - Mortgage debt, comprising 74.4% of total consumer debt, increased by 3.1% year-over-year, while new mortgage originations hit an all-time low [4] - The average loan value for new mortgages reached $321.7K, up 3.1% from the previous year [4] Mortgage Market Dynamics - Alberta's housing market showed resilience with a 10.6% increase in new mortgage originations compared to Q1 2023 [5] - Consumers are extending mortgage lengths to reduce payments, with 37.1% extending amortization terms [6] - Payment shocks are affecting consumers, with nearly 9% of mortgage renewals seeing monthly payments increase by over $500 [6] Delinquency Rates and Financial Strain - Delinquency rates for credit products are rising, with over 1.26 million consumers missing at least one payment in Q1 2024, a 12.2% increase from Q1 2023 [10] - Ontario, British Columbia, and Quebec experienced significant increases in delinquency rates, with Ontario's rate rising by 28.18% year-over-year [14] - Credit card delinquencies are increasing, with full-payment rates dropping from 65.6% to 64.5% [11] Age and Regional Analysis - Average debt for Canadians in Q1 2024 was $21,276, with a year-over-year increase of 1.77% [14] - The delinquency rate for the 18-25 age group was 1.80%, showing a 7.02% increase year-over-year [13] - Major cities like Toronto and Vancouver have seen delinquency rates rise above pre-pandemic levels, with Toronto's rate increasing from 0.09% to 0.14% [8]

Core Insights - Akero Therapeutics announced significant data from its lead product candidate efruxifermin (EFX) at the EASL Congress 2024, highlighting its potential in treating metabolic dysfunction-associated steatohepatitis (MASH) [1][7] Study Results - The Phase 2b HARMONY study demonstrated that EFX met its primary endpoint, showing ≥1-stage improvement in fibrosis after 24 weeks for both 50 mg (41%, p<0.05) and 28 mg (39%, p<0.05) dose groups, compared to 20% for placebo [2] - At Week 96, response rates for fibrosis improvement increased to 75% (p<0.001) for the 50 mg group and 46% (p=0.07) for the 28 mg group, versus 24% for placebo [2] - The study also reported that 36% (p<0.01) and 31% (p<0.01) of patients in the 50 mg and 28 mg groups, respectively, achieved a 2-stage improvement in fibrosis without worsening of MASH, significantly higher than the placebo rate of 3% [3] Treatment Efficacy - EFX treatment showed sustained and expanded treatment response over 96 weeks, with over 80% of EFX-treated patients maintaining improved fibrosis from Week 24 to Week 96 [4] - Among non-responders at Week 24, 63% of patients treated with 50 mg EFX experienced improvement in fibrosis by Week 96, compared to a placebo rate of 21% [4] - The results indicate EFX was well tolerated, with no liver injury or decompensation events reported [4] Biomarker Analysis - A post-hoc analysis revealed significant changes in key biomarkers associated with collagen synthesis and degradation, indicating EFX's effects on extracellular matrix remodeling in the liver [5] - EFX treatment led to decreased interstitial collagens and regeneration of structural collagens, correlating with reductions in liver injury markers [5] Company Overview - Akero Therapeutics is focused on developing treatments for serious metabolic diseases, including MASH, with EFX being evaluated in multiple ongoing clinical trials [12] - MASH affects over 17 million Americans and is a leading cause of liver transplants and cancer in the US and Europe [11]

Core Viewpoint - Equifax will participate in several investor conferences in June 2024, showcasing its commitment to engaging with investors and providing insights into its operations and strategies [1][2]. Group 1: Upcoming Events - Mark W. Begor, CEO, and John Gamble, CFO, will attend the Baird Global Consumer, Technology & Services Conference on June 4, 2024, featuring a Fireside Chat at 12:15 P.M. Eastern Time [1]. - The Stifel Cross Sector Insight Conference will take place on June 5, 2024, with a Fireside Chat scheduled for 3:00 P.M. Eastern Time [1]. - Trevor Burns, Senior Vice President of Corporate Investor Relations, will attend the JP Morgan Canada 1X1 Forum on June 11, 2024 [2]. Group 2: Investor Engagement - Investors are invited to join live webcasts of the Fireside Chat events, with replays available within 24 hours on the company's Investor Relations website [2]. Group 3: Company Overview - Equifax is a global data, analytics, and technology company that plays a crucial role in the global economy by assisting financial institutions, companies, employers, and government agencies in making informed decisions [3]. - The company is headquartered in Atlanta and employs nearly 15,000 individuals worldwide, operating or investing in 24 countries across North America, Central and South America, Europe, and the Asia Pacific region [3].